Investing Profile

Phil Ferneau

InvestorVCFounderAngel

Co-Founder and Managing Partner at Borealis Ventures

borealis.vc/teamNew Hampshire

Your Intro Paths to Phil Ferneau

Signal uses Gmail to reveal intro paths. Email content is never read.

Networks Phil is a member of

Dartmouth College Network

233 CONNECTIONS

The Tuck School of Business at Dartmouth Network

53 CONNECTIONS

University of Virginia School of Law Network

16 CONNECTIONS

University of Virginia School of Law Network

16 CONNECTIONS

Dartmouth Institute Network

13 CONNECTIONS

Find Phil Ferneau on

Current Investing Position

Borealis Ventures Managing Partner

Investment Range

$250K - $750K

Sweet Spot

$500K

Investments On Record

Current Fund Size

$100M

Phil Ferneau is on these Sector & Stage Rankings

Health IT (Series A)Health & Hospital Services (Series B)Health & Hospital Services (Series A)Digital Health (Series B)Health IT (Seed)Health IT (Series B)Digital Health (Series A)Digital Health (Seed)Health & Hospital Services (Seed)

Phil Ferneau's Investments On Record (6)

Company	StageDateRound Size	Total Raised
Ankyra	Series BNov 2021$45M	$45M
Co-investors: Terry McGuire (Polaris Partners), Ajay Royan (Mithril Capital Management LLC)
Orbit Discovery	SeedJul 2021$8M Series AMay 2018$9M	$17M
Co-investors: Nicholas Dixon-Clegg (Oxford Science Enterprises)
Compass Therapeutics	Series UnknownJun 2020$60M	$160M
Co-investors: Krishna Yeshwant (GV (Google Ventures)), Stephen Squinto (OrbiMed), Peter Thiel (The Founders Fund), Carl Gordon (OrbiMed Advisors), Julie Sunderland (Biomatics Capital Partners), George Godula (Life Biosciences), Ben Auspitz (Curie.Bio)
Avitide	Series EJun 2017$12M Series CAug 2015$8M Series AMar 2013$1M	$21M
Co-investors: Terry McGuire (Polaris Partners), Mike Ross (SV Health Investors)
Avedro	Series DMar 2013$43M	$180M
Co-investors: Jonathan Silverstein (OrbiMed), Doug Cole (Flagship Pioneering), Hongbo Lu (Lilly Asia Ventures), Bruce Cleveland (Obo), Gil Kliman (InterWest), David Berry (Flagship Ventures), Eric Sillman (Aperture Venture Partners)
Vets First Choice	Series UnknownJun 2012$4M	$4M
Co-investors: Kevin Bitterman (Polaris Partners)

Phil Ferneau's Experience

Adjunct Professor Dartmouth InstitutePresent

Investor GlycoFiPresent

Board director and founding investor Avedro, Inc.Present

Board director and founding investor Glaukos CorporationPresent

Board Director and Lead Investor M2SPresent

Investor AdimabPresent

Board Director and Investor Vets First ChoicePresent

Board Director and Investor AvitidePresent

Board Director and Investor Avitide, LLC, a Repligen CompanyPresent

Board Director and Investor Compass Therapeutics LLCPresent

Board Director and Investor Compass Therapeutics Inc.Present

Investor Evox Therapeutics LtdPresent

Investor and Former Board Director Orbit DiscoveryPresent

Board Director and Investor Orbit DiscoveryPresent

Board Observer and Investor TeckroPresent

Board Director and Investor OvationPresent

Board Director and Investor Ovation.ioPresent

Investor and Former Board Director Triveni BioPresent

Board Director and Investor Amagma TherapeuticsPresent

Investor and Former Board Director T-Cypher BioPresent

Board Director and Investor T-Cypher BioPresent

Board Director and Investor Ankyra TherapeuticsPresent

Co-Founder and Managing Partner Borealis VenturesPresent

Phil Ferneau's Education

Dartmouth College A.B. Government

University of Virginia School of Law J.D. J. of Law & Politics

The Tuck School of Business at Dartmouth MBA Business

University of Virginia School of Law J.D. Law

Investors who invest with Phil Ferneau

Scouts & Angels Affiliated With Phil Ferneau